New hope for advanced cancers: first human trial of NUV-1511 begins
NCT ID NCT06334432
First seen Feb 01, 2026 · Last updated May 09, 2026 · Updated 14 times
Summary
This study tests a new drug called NUV-1511 in people with advanced solid tumors that have not responded to other treatments. The trial has two parts: first, finding a safe dose, and second, checking if the drug shrinks tumors in specific cancers like breast, prostate, pancreatic, and ovarian cancer. About 466 adults will take part to see if NUV-1511 can help control their disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carolina BioOncology Institute
Huntersville, North Carolina, 28078, United States
-
Fred Hutchinson
Seattle, Washington, 98109, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Karmanos Cancer Center
Detroit, Michigan, 48201, United States
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
NEXT Oncology
Irving, Texas, 75038, United States
-
NEXT Oncology
Fairfax, Virginia, 22031, United States
-
START Mountain
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.